AbCellera Biologics (ABCL) Tax Provisions (2021 - 2026)
AbCellera Biologics (ABCL) posted Tax Provisions of -$6.4 million for Q1 2026, up 39.62% on a QoQ basis from -$10.6 million in Q4 2025, and up 13.46% year-over-year from -$5.6 million in Q1 2025.
AbCellera Biologics (ABCL) Tax Provisions (2021 - 2026) Analysis & Trends
AbCellera Biologics' Tax Provisions history runs 6 years deep, the most recent figure standing at -$6.4 million for Q1 2026.
- Quarterly Tax Provisions rose 13.46% year-over-year to -$6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$30.2 million (up 29.4% YoY) and the FY2025 annual result came in at -$31.2 million, up 16.93% from the prior year.
- Tax Provisions was -$6.4 million for Q1 2026 at AbCellera Biologics, up from -$10.6 million in the prior quarter.
- Across five years, Tax Provisions topped out at $62.2 million in Q1 2022 and bottomed at -$12.6 million in Q4 2024.
- A 5-year average of -$1.3 million and a median of -$7.4 million in 2025 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions jumped 655.76% — and 2023, when it slumped 7301.98%.
- AbCellera Biologics' Tax Provisions stood at -$1.5 million in 2022, then increased by 4.41% to -$1.5 million in 2023, then tumbled by 769.08% to -$12.6 million in 2024, then advanced by 16.36% to -$10.6 million in 2025, then surged by 39.62% to -$6.4 million in 2026.
- Business Quant data shows ABCL's Tax Provisions at -$6.4 million in Q1 2026, -$10.6 million in Q4 2025, and -$11.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | AbCellera Biologics | 1.72 Bn | 1.72 Bn | - | -6.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.37 Mn |
| Dec 31, 2025 | -10.55 Mn |
| Sep 30, 2025 | -11.65 Mn |
| Jun 30, 2025 | -1.62 Mn |
| Mar 31, 2025 | -7.36 Mn |
| Dec 31, 2024 | -12.62 Mn |
| Sep 30, 2024 | -11.53 Mn |
| Jun 30, 2024 | -11.26 Mn |
| Mar 31, 2024 | -2.14 Mn |
| Dec 31, 2023 | -1.45 Mn |
| Sep 30, 2023 | -10.67 Mn |
| Jun 30, 2023 | -7.48 Mn |
| Mar 31, 2023 | -8.04 Mn |
| Dec 31, 2022 | -1.52 Mn |
| Sep 30, 2022 | 19.96 Mn |
| Jun 30, 2022 | -101,000.00 |
| Mar 31, 2022 | 62.24 Mn |
| Dec 31, 2021 | 24.76 Mn |
| Sep 30, 2021 | -3.59 Mn |
| Jun 30, 2021 | 250,000.00 |